<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30223800</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>11</Month>            <Day>05</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1471-2407</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>18</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>17</Day>                    </PubDate>                </JournalIssue>                <Title>BMC cancer</Title>                <ISOAbbreviation>BMC Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.</ArticleTitle>            <Pagination>                <MedlinePgn>897</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-018-4791-x</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The only available predictive models for the outcome of breast cancer patients in New Zealand (NZ) are based on data in other countries. We aimed to develop and validate a predictive model using NZ data for this population, and compare its performance to a widely used overseas model, the Nottingham Prognostic Index (NPI).</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">We developed a model to predict 10-year breast cancer-specific survival, using data collected prospectively in the largest population-based regional breast cancer registry in NZ (Auckland, 9182 patients), and assessed its performance in this data set (internal validation) and in an independent NZ population-based series of 2625 patients in Waikato (external validation). The data included all women with primary invasive breast cancer diagnosed from 1 June 2000 to 30 June 2014, with follow up to death or Dec 31, 2014. We used multivariate Cox proportional hazards regression to assess predictors and to calculate predicted 10-year breast cancer mortality, and therefore survival, probability for each patient. We assessed observed survival by the Kaplan Meier method. We assessed discrimination by the C statistic, and calibration by comparing predicted and observed survival rates for patients in 10 groups ordered by predicted 10-year survival. We compared this NZ model with the Nottingham Prognostic Index (NPI) in this validation data set.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Discrimination was good: C statistics were 0.84 for internal validity and 0.83 for an independent external validity. For calibration, for both internal and external validity the predicted 10-year survival probabilities in all groups of patients, ordered by predicted survival, were within the 95% confidence intervals (CI) of the observed Kaplan-Meier survival probabilities. The NZ model showed good discrimination even within the prognostic groups defined by the NPI.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These results for the New Zealand model show good internal and external validity, transportability, and potential clinical value of the model, and its clear superiority over the NPI. Further research is needed to assess other potential predictors, to assess the model's performance in specific subgroups of patients, and to compare it to other models, which have been developed in other countries and have not yet been tested in NZ.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Elwood</LastName>                    <ForeName>J Mark</ForeName>                    <Initials>JM</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5730-4791</Identifier>                    <AffiliationInfo>                        <Affiliation>Epidemiology and Biostatistics, School of Population Health, University of Auckland, 261 Morrin Road, Private Bag 92019, Auckland Mail Centre, Auckland, 1142, New Zealand. mark.elwood@auckland.ac.nz.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tawfiq</LastName>                    <ForeName>Essa</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Epidemiology and Biostatistics, School of Population Health, University of Auckland, 261 Morrin Road, Private Bag 92019, Auckland Mail Centre, Auckland, 1142, New Zealand.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>TinTin</LastName>                    <ForeName>Sandar</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Epidemiology and Biostatistics, School of Population Health, University of Auckland, 261 Morrin Road, Private Bag 92019, Auckland Mail Centre, Auckland, 1142, New Zealand.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Marshall</LastName>                    <ForeName>Roger J</ForeName>                    <Initials>RJ</Initials>                    <AffiliationInfo>                        <Affiliation>Epidemiology and Biostatistics, School of Population Health, University of Auckland, 261 Morrin Road, Private Bag 92019, Auckland Mail Centre, Auckland, 1142, New Zealand.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Phung</LastName>                    <ForeName>Tung M</ForeName>                    <Initials>TM</Initials>                    <AffiliationInfo>                        <Affiliation>Epidemiology and Biostatistics, School of Population Health, University of Auckland, 261 Morrin Road, Private Bag 92019, Auckland Mail Centre, Auckland, 1142, New Zealand.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Campbell</LastName>                    <ForeName>Ian</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>Waikato Clinical Campus, Department of Surgery, University of Auckland, Hamilton, New Zealand.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Waikato District Health Board, Hamilton, New Zealand.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Harvey</LastName>                    <ForeName>Vernon</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>Regional Cancer and Blood Centre, Auckland City Hospital, Auckland, New Zealand.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lawrenson</LastName>                    <ForeName>Ross</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Waikato Clinical Campus, Department of Surgery, University of Auckland, Hamilton, New Zealand.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>The University of Waikato, Hamilton, 3240, New Zealand.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Waikato District Health Board, Hamilton, New Zealand.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>1116017</GrantID>                    <Agency>Auckland Medical Research Foundation</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>17</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>BMC Cancer</MedlineTA>            <NlmUniqueID>100967800</NlmUniqueID>            <ISSNLinking>1471-2407</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011960">Receptors, Estrogen</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol. 2014 Oct;38(5):638-44</RefSource>                <PMID Version="1">25037979</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 1999 Jun;35(6):908-12</RefSource>                <PMID Version="1">10533470</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Z Med J. 2017 Dec 15;130(1467):50-61</RefSource>                <PMID Version="1">29240740</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Epidemiol. 2016 Oct;78:4-6</RefSource>                <PMID Version="1">27060388</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 1994;32(3):281-90</RefSource>                <PMID Version="1">7865856</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2015 Mar 17;112(6):983-91</RefSource>                <PMID Version="1">25675148</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Jpn J Clin Oncol. 2010 Jun;40(6):508-12</RefSource>                <PMID Version="1">20110242</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):675-80</RefSource>                <PMID Version="1">20160274</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 1992;22(3):207-19</RefSource>                <PMID Version="1">1391987</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2012 Aug 21;107(5):800-7</RefSource>                <PMID Version="1">22850554</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2010 Sep 7;103(6):776-86</RefSource>                <PMID Version="1">20823886</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2011 Aug;128(3):827-35</RefSource>                <PMID Version="1">21327471</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 1996 Jul 4;13(1):63-72</RefSource>                <PMID Version="1">8700555</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lifetime Data Anal. 1998;4(2):109-20</RefSource>                <PMID Version="1">9658770</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2012 May;48(7):982-9</RefSource>                <PMID Version="1">22366561</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Histopathology. 1991 Nov;19(5):403-10</RefSource>                <PMID Version="1">1757079</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2015 Mar 3;112(5):912-7</RefSource>                <PMID Version="1">25590666</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2014 Jan 20;32(3):238-50</RefSource>                <PMID Version="1">24344212</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 1982 Mar;45(3):361-6</RefSource>                <PMID Version="1">7073932</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Epidemiol. 1995 Dec;48(12):1503-10</RefSource>                <PMID Version="1">8543964</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cancer Res Clin Oncol. 2010 Jun;136(6):939-44</RefSource>                <PMID Version="1">19946706</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2005 Apr 20;23(12):2716-25</RefSource>                <PMID Version="1">15837986</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Causes Control. 2017 Dec;28(12):1417-1427</RefSource>                <PMID Version="1">29027594</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2001 Mar;37(5):591-6</RefSource>                <PMID Version="1">11290434</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Public Health. 2015 May;129(5):549-54</RefSource>                <PMID Version="1">25753278</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Invest. 2009 Mar;27(3):235-43</RefSource>                <PMID Version="1">19291527</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Public Health. 2015 Jan 31;15:46</RefSource>                <PMID Version="1">25637343</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2011 Nov 20;29(33):4365-72</RefSource>                <PMID Version="1">22010013</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Epidemiol. 2005 May;58(5):475-83</RefSource>                <PMID Version="1">15845334</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Med Res Methodol. 2015 Oct 12;15:82</RefSource>                <PMID Version="1">26459415</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Intern Med. 2015 Jan 6;162(1):W1-73</RefSource>                <PMID Version="1">25560730</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2016 Feb 19;16:129</RefSource>                <PMID Version="1">26896237</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2015;16(6):2465-72</RefSource>                <PMID Version="1">25824782</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2010 Sep 20;28(27):4129-34</RefSource>                <PMID Version="1">20713855</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2018 Jan 8;18(1):58</RefSource>                <PMID Version="1">29310606</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Pathol Lab Med. 2010 Jul;134(7):e48-72</RefSource>                <PMID Version="1">20586616</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Breast Cancer. 2017 Apr;17(2):117-126</RefSource>                <PMID Version="1">27592541</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2004 Dec 1;101(11):2509-15</RefSource>                <PMID Version="1">15495180</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Kidney Int. 2008 Sep;74(5):560-5</RefSource>                <PMID Version="1">18596735</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2001 Feb 15;19(4):980-91</RefSource>                <PMID Version="1">11181660</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Surg Oncol. 2011 May;37(5):411-7</RefSource>                <PMID Version="1">21371853</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2016 Apr 07;11(4):e0153206</RefSource>                <PMID Version="1">27054698</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Public Health. 2016 Mar;132:3-12</RefSource>                <PMID Version="1">26872738</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Causes Control. 2015 Dec;26(12):1813-24</RefSource>                <PMID Version="1">26407955</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2017 May 22;19(1):58</RefSource>                <PMID Version="1">28532503</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001940" MajorTopicYN="N">Breast</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000073116" MajorTopicYN="N">Cancer Survivors</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009361" MajorTopicYN="N">Neoplasm Invasiveness</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009520" MajorTopicYN="N">New Zealand</DescriptorName>                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011379" MajorTopicYN="Y">Prognosis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011960" MajorTopicYN="N">Receptors, Estrogen</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Mortality</Keyword>            <Keyword MajorTopicYN="N">New Zealand</Keyword>            <Keyword MajorTopicYN="N">Nottingham prognostic index</Keyword>            <Keyword MajorTopicYN="N">Predictive model</Keyword>            <Keyword MajorTopicYN="N">Prognosis</Keyword>            <Keyword MajorTopicYN="N">Survival</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>26</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>09</Month>                <Day>03</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30223800</ArticleId>            <ArticleId IdType="doi">10.1186/s12885-018-4791-x</ArticleId>            <ArticleId IdType="pii">10.1186/s12885-018-4791-x</ArticleId>            <ArticleId IdType="pmc">PMC6142675</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>